T1	Participants 0 97	Reducing Sitting Time After Stroke: A Phase II Safety and Feasibility Randomized Controlled Trial
T2	Participants 189 205	stroke survivors
T3	Participants 307 316	Community
T4	Participants 331 384	Stroke survivors (N=35; 22 men; mean age, 66.9Â±12.7y)
T5	Participants 479 498	(intervention group
T6	Participants 528 559	attention-matched control group
T7	Participants 1105 1130	Thirty-three participants
T8	Participants 1160 1177	Four participants
